Ahlada Engineers manufactures and installs steel doors, windows, and specialized clean-room equipment for industrial, commercial, and residential sectors, primarily serving the Indian market.
The company lacks a durable moat as evidenced by a 95% collapse in net profit and a 23% revenue decline in FY26, despite claims of growing demand. Low net margins (avg 4.2%) and poor ROCE (12.2%) indicate a commodity-like business with no pricing power or scale advantage.
Management has failed to generate value from reinvested earnings, with EPS declining at a 44.8% CAGR. Capital has been tied up in massive advances to suppliers (₹63 crore) that yield no return, while the company suspended dividends in FY26 due to liquidity constraints.
The company's collapse was precipitated by the total write-off of the massive supplier advances, which were already flagged as a recoverability risk. As revenue continued its double-digit decline, the razor-thin interest coverage evaporated, leading to a liquidity crunch that the company could not survive. The dependence on the Tata Steel model proved fatal when margins were squeezed further, and the revolving door of financial leadership left no one to steer the ship as the business transitioned from a low-margin commodity player to a terminal insolvency case.
RichFakir rates Ahlada Engineers Ltd's business quality as poor — 23/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Ahlada Engineers Ltd is trading about 33% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Ahlada Engineers Ltd is: Not rated. A poor business at a cheap price — it does not make our shortlist right now. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Ahlada Engineers Ltd's fair value is about ₹53 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →